Table 1.

Characteristics of the cancer patients; numbers (n), percentage (%), median, range, and means

Characteristics	Cancer site				Total
Breast	Colon	Lung	Lymphoma
Cases/cancer deaths, n	202/68	37/22	193/168	124/55	556/313
Sex, cases/cancer deaths, n
Men	0	23/15	122/105	79/35	224/155
Women	202/68	14/7	71/63	45/20	332/158
Age at diagnosis
Years, median (range)	55 (34–75)	58 (32–75)	59 (39–82)	57 (39–79)	57 (32–82)
Time between prediagnostic serum sampling and diagnosis
Years, median (range)	11.7 (1.1–28.9)	13.5 (3.0–22.1)	17.7 (2.3–34.4)	15.2 (2.9–31.8)	14.4 (1.1–34.4)
Prediagnostic 25-OHD, nmol/L, median (range)	62.5 (18.0–119.0)	61.0 (24.0–129.0)	64.5 (17.4–132.4)	64.4 (32.3–142.5)	63.3 (17.4–142.5)
1 [<46 nmol/L], mean (n)	36.3 (44)	36.0 (7)	37.7 (41)	40.1 (22)	37.5 (114)
2 [46–61 nmol/L], mean (n)	53.9 (56)	55.1 (14)	54.7 (50)	54.7 (34)	54.5 (154)
3 [62–81 nmol/L], mean (n)	71.4 (65)	72.6 (10)	71.9 (58)	70.5 (35)	71.4 (168)
4 [≥82 nmol/L], mean (n)	94.3 (37)	101.3 (6)	97.4 (44)	97.7 (33)	96.7 (120)
Season-standardized prediagnostic 25-OHD nmol/L, median (range)	61.4 (20.9–139.5)	60.7 (25.9–111.6)	64.0 (18.2–151.7)	66.5 (34.8–128.7)	63.2 (18.2–151–7)
Diagnostic 25-OHD, nmol/L, median (range)	72.0 (13.0–177.0)	62.0 (24.0–124.0)	55.0 (15.0–184.0)	59.5 (16.0–185.0)	62.5 (13.0–185.0)
1 [<46 nmol/L], mean (n)	34.7 (29)	38.0 (10)	34.8 (60)	35.9 (39)	35.3 (138)
2 [46–61 nmol/L], mean (n)	54.0 (47)	50.0 (8)	52.7 (55)	54.1(26)	53.3 (136)
3 [62–81 nmol/L], mean (n)	71.5 (48)	71.8 (13)	71.4 (40)	70.2 (33)	71.2 (134)
4 [≥82 nmol/L], mean (n)	99.6 (78)	97.2 (6)	98.1 (38)	103.6 (26)	99.8 (148)
Season-standardized diagnostic 25-OHD nmol/L, median (range)	74.2 (13.6–151.9)	63.9 (26.9–157.6)	56.6 (15.7–152.7)	59.3 (16.8–180.6)	63.5 (13.6–180.6)